AN
50
7
CRM
70
18
MAR
71
3
CNX
49
3
IR
58
3
CNP
49
-6
HAL
50
2
FLS
61
13
RSG
47
2
PCG
74
2
ADT
50
2
AVGO
54
12
NKE
28
-12
LRCX
62
6
AME
72
6
APD
45
-2
M
58
5
EMR
64
5
BK
74
5
AIZ
78
2
AN
50
7
CRM
70
18
MAR
71
3
CNX
49
3
IR
58
3
CNP
49
-6
HAL
50
2
FLS
61
13
RSG
47
2
PCG
74
2
ADT
50
2
AVGO
54
12
NKE
28
-12
LRCX
62
6
AME
72
6
APD
45
-2
M
58
5
EMR
64
5
BK
74
5
AIZ
78
2
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
71

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$35.99
Seasonality Move:
2.42%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
71
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $35.76. The Score for ITDD is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $35.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 55.8 Buy
Chaikin Money Flow: 1106 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.07 - 35.81) Buy
Bollinger Bands (100): (34.15 - 35.61) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.68 Buy
20-day SMA: 35.57 Buy
50-day SMA: 35.41 Buy
200-day SMA: 33.17 Buy
8-day EMA: 35.64 Buy
20-day EMA: 35.57 Buy
50-day EMA: 35.34 Buy
200-day EMA: 33.67 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):